Clinical Trial Update: Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma [Phase 1, Phase 2]

View source ↗

Summary

A pediatric Phase 1/2 study evaluated erlotinib in combination with radiation therapy for newly diagnosed glioma, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Glioma

Drugs mentioned

• Tarceva (erlotinib)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Brain and Central Nervous System Tumors | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-04-29